返回 Agenda
Session 5: Panel Discussion
Session Chair(s)
Rei Maeda
Consultant, Independent Consultant for Drug PV, Japan
Hiroyuki Murakami, PHD
Duputy Review Director, Office of New Drug I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Nihonbashi Life Science Building - Hall 201
2017 年 05 月 30 日 9:20 上午 - 2017 年 05 月 30 日 5:45 下午
2-3-11 Nihonbashi-honcho, Chuo-ku, Tokyo, 103-0023 Japan
返回 Agenda
Consultant, Independent Consultant for Drug PV, Japan
Duputy Review Director, Office of New Drug I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan